Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Societal CDMO Adds New Staff | Contract Pharma

What are you searching for?

Sign in

Societal CDMO Adds New Staff

Approves inducement stock option grants to purchase an aggregate of 87,690 shares of Societal CDMO’s common stock.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Societal CDMO, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, has added new employees to fill open positions throughout the company.
 
In connection with the hiring of these personnel, the compensation committee of Societal CDMO’s board of directors approved inducement stock option grants to purchase an aggregate of 87,690 shares of Societal CDMO’s common stock. The option awards were granted pursuant to the NASDAQ inducement grant exception as a component of each individual’s employment compensation and were granted as an inducement material to his or her acceptance of employment with Societal CDMO in accordance with NASDAQ Listing Rule 5635(c)(4). 
 
The option awards will have an exercise price equal to the closing price of Societal CDMO’s common stock on June 30, 2022 and a ten-year term and will vest in equal monthly installments over four years.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters